Rochester, Minnesota 55905


Purpose:

The purpose of this study is to determine the response rate and overall survival in patients that have been diagnosed with mesothelioma and will undergo chemotherapy, surgery and intensity modified radiation therapy (IMRT) as part of their standard of care.


Study summary:

The investigators will consent patients that have been diagnosed with mesothelioma and will undergo chemotherapy followed by surgery and then IMRT as their standard of care. The investigators will collect data from past and future medical records as well as data regarding their health status for their lifetime by reviewing life status, treatment status and CT scans.


Criteria:

Inclusion Criteria: - Subject provides informed consent - Subject is >18 years of age - Subject is deemed competent for making medical decisions - Subject is scheduled to undergo chemotherapy followed by surgery and then IMRT - Subject is a surgical candidate - A negative pregnancy test is required in women of child-bearing potential, as standard of care. Exclusion Criteria: •Subject is <18 years old.


NCT ID:

NCT02613312


Primary Contact:

Principal Investigator
Dennis Wigle, MD, PhD
Mayo Clinic

Karlyn Pierson, RN
Phone: 507-293-0807
Email: pierson.karlyn@mayo.edu


Backup Contact:

Email: lechtenberg.bettie@mayo.edu
Bettie Lechtenberg, MBA
Phone: 507-293-0807


Location Contact:

Rochester, Minnesota 55905
United States

Karlyn E Pierson, RN
Phone: 507-538-1960
Email: pierson.karlyn@mayo.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.